Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test
1 other identifier
observational
38
1 country
1
Brief Summary
Aim of the study is to investigate whether the Covid-19 is found in the vaginal swab samples of female patients diagnosed with covid-19, to evaluate the presence of Covid-19 and the risk of transmission of Covid-19 by intercourse or vaginal delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2020
CompletedFirst Submitted
Initial submission to the registry
June 17, 2020
CompletedFirst Posted
Study publicly available on registry
June 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedJanuary 12, 2021
January 1, 2021
25 days
June 17, 2020
January 11, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Vaginal fluid Covid-19 PCR test result
Vaginal fluid Covid-19 test positivity rate for patients whose nasofarengeal test is positive
1 month
Secondary Outcomes (1)
becoming negative from positive
2 month
Study Arms (1)
Covid-19 positive women
Women with nasofarangeal Covid-19 PCR test is positive
Interventions
Vaginal fluid samples are tested for Covid-19
Eligibility Criteria
Women who are older than18 years old, who are considered to be covid-19 clinically and radiologically positive or nasofarengeal Covid-19 PCR test is positive will be included. Patients previously treated for covid-19 will be excluded from the study.
You may qualify if:
- Women who are positive nasofarengeal Covid-19 PCR test result
- Women who are 18 years or older
- Women who had sexual intercourse before
You may not qualify if:
- who had medical treatment for Covid-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Acibadem Maslak Hospital
Istanbul, 34457, Turkey (Türkiye)
Related Publications (2)
Cui P, Chen Z, Wang T, Dai J, Zhang J, Ding T, Jiang J, Liu J, Zhang C, Shan W, Wang S, Rong Y, Chang J, Miao X, Ma X, Wang S. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract. Am J Obstet Gynecol. 2020 Jul;223(1):131-134. doi: 10.1016/j.ajog.2020.04.038. Epub 2020 May 4. No abstract available.
PMID: 32376320BACKGROUNDQiu L, Liu X, Xiao M, Xie J, Cao W, Liu Z, Morse A, Xie Y, Li T, Zhu L. SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection. Clin Infect Dis. 2020 Jul 28;71(15):813-817. doi: 10.1093/cid/ciaa375.
PMID: 32241022RESULT
Biospecimen
Vaginal fluid
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD,Assistant Professor
Study Record Dates
First Submitted
June 17, 2020
First Posted
June 18, 2020
Study Start
June 15, 2020
Primary Completion
July 10, 2020
Study Completion
November 30, 2020
Last Updated
January 12, 2021
Record last verified: 2021-01